AKBA
Akebia Therapeutics Inc
Price:  
2.13 
USD
Volume:  
1,307,454.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKBA Relative Valuation

-408.8%
Upside

As of 2025-02-16, the Relative Valuation of Akebia Therapeutics Inc (AKBA) is (6.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.13 USD, the upside of Akebia Therapeutics Inc based on Relative Valuation is -408.8%.

The range of the Relative Valuation is (5.36) - (7.45) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 18.3x - 39.0x 28.8x
Forward P/E multiples 25.4x - 35.3x 33.6x
Fair Price (5.36) - (7.45) (6.58)
Upside -351.8% - -449.5% -408.8%
2.13 USD
Stock Price
(6.58) USD
Fair Price

AKBA Relative Valuation - Historical P/E Data

Date P/E
2025-02-14 -10.10
2025-02-13 -10.15
2025-02-12 -10.01
2025-02-11 -9.96
2025-02-10 -9.96
2025-02-07 -10.15
2025-02-06 -10.25
2025-02-05 -10.29
2025-02-04 -10.15
2025-02-03 -10.06
2025-01-31 -10.63
2025-01-30 -10.91
2025-01-29 -10.91
2025-01-28 -10.86
2025-01-27 -10.91
2025-01-24 -11.29
2025-01-23 -11.34
2025-01-22 -11.34
2025-01-21 -11.24
2025-01-17 -9.82
2025-01-16 -9.16
2025-01-15 -9.20
2025-01-14 -8.97
2025-01-13 -8.87
2025-01-10 -8.30
2025-01-08 -8.49
2025-01-07 -8.82
2025-01-06 -8.87
2025-01-03 -9.11
2025-01-02 -9.01
2024-12-31 -9.01
2024-12-30 -8.78
2024-12-27 -9.25
2024-12-26 -9.16
2024-12-24 -8.82
2024-12-23 -8.78
2024-12-20 -8.68
2024-12-19 -8.49
2024-12-18 -8.35
2024-12-17 -8.87
2024-12-16 -8.73
2024-12-13 -8.78
2024-12-12 -8.63
2024-12-11 -9.11
2024-12-10 -9.39
2024-12-09 -9.68
2024-12-06 -9.72
2024-12-05 -9.58
2024-12-04 -9.63
2024-12-03 -9.68